This is a Validated Antibody Database (VAD) review about rat 8 oxo dGTPase, based on 4 published articles (read how Labome selects the articles), using 8 oxo dGTPase antibody in all methods. It is aimed to help Labome visitors find the most suited 8 oxo dGTPase antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
8 oxo dGTPase synonym: Mth1; 7,8-dihydro-8-oxoguanine triphosphatase; 2-hydroxy-dATP diphosphatase; 8-oxo-dGTPase; mutT human homolog (8-oxo-dGTPase); nucleoside diphosphate-linked moiety X motif 1; nudix (nucleoside diphosphate linked moiety X)-type motif 1; nudix motif 1; nudix-type motif 1

Knockout validation
Novus Biologicals
rabbit polyclonal
  • western blot knockout validation; human; 1:1000; loading ...; fig s1b
Novus Biologicals 8 oxo dGTPase antibody (Novus Biologicals, NB100-109) was used in western blot knockout validation on human samples at 1:1000 (fig s1b). Nat Commun (2018) ncbi
Novus Biologicals
rabbit polyclonal
  • western blot knockout validation; human; 1:1000; loading ...; fig s1b
Novus Biologicals 8 oxo dGTPase antibody (Novus Biologicals, NB100-109) was used in western blot knockout validation on human samples at 1:1000 (fig s1b). Nat Commun (2018) ncbi
rabbit polyclonal
  • western blot; human; fig 2
Novus Biologicals 8 oxo dGTPase antibody (novus Biologicals, NB100-109) was used in western blot on human samples (fig 2). Nat Methods (2015) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:150; fig 1a
In order to study how pre-transformation MTH1 levels in immortalized cells influence HRASV12-induced oncogenic transformation, Novus Biologicals 8 oxo dGTPase antibody (Novus Biologicals, NB100-C109) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1a). Oncotarget (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 2
Novus Biologicals 8 oxo dGTPase antibody (novus Biologicals, NB100-109) was used in western blot on human samples (fig 2). Oncogene (2015) ncbi
Articles Reviewed
  1. Zou X, Owusu M, Harris R, Jackson S, Loizou J, Nik Zainal S. Validating the concept of mutational signatures with isogenic cell models. Nat Commun. 2018;9:1744 pubmed publisher
  2. Huber K, Olek K, Müller A, Tan C, Bennett K, Colinge J, et al. Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling. Nat Methods. 2015;12:1055-7 pubmed publisher
  3. Giribaldi M, Muñoz A, Halvorsen K, Patel A, Rai P. MTH1 expression is required for effective transformation by oncogenic HRAS. Oncotarget. 2015;6:11519-29 pubmed
  4. Patel A, Burton D, Halvorsen K, Balkan W, Reiner T, Perez Stable C, et al. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways. Oncogene. 2015;34:2586-96 pubmed publisher